MIPPA law delays implementation of Medicaid's average manufacturers price for generic drugs until Oct. 1, 2009.
To the relief of pharmacists, Congress overrode President Bush's veto of the Medicare Improvements for Patients and Providers Act (MIPPA) of 2008. The new law delays the implementation of both Medicaid's average manufacturers price for generic drugs until Oct. 1, 2009, as well as the first round of Medicare's durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) competitive bid program. It also requires prompt pay of Medicare Part D claims.
Assessing Financial Impacts of Pharmacist-Led Interventions in Pediatric Ambulatory Care
December 5th 2023According to a poster abstract presented at the ASHP Midyear Clinical Meeting & Exhibition, specialty pharmacy services were used for a variety of conditions that have been reported in adult populations.